Personalized testing to guide treatment for epilepsy
Treatments studied
Part of Brain & nervous system clinical trials.
This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 16–55 (for one group) or 18–55 (for another group)
- You either have suspected epilepsy without an official diagnosis, or you have a confirmed epilepsy diagnosis
- You must be able to have MRI scans (no pacemakers/metal implants, and you can tolerate being in the scanner)
- If you’re in the group that uses PET scans, you must be able to complete PET testing
- You must be able to safely take levetiracetam or lamotrigine, and avoid interacting medicines
- No pregnancy or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for adults with uncontrolled epilepsy who have been taking a high dose of Levetiracetam alone for at least a year. It tests whether taking Levetiracetam three times a day works better than the usual schedule.
This study tests how well a specific brain-recording device works during a procedure used to map seizure origins in people with drug-resistant, disabling focal epilepsy. It may help doctors plan treatment by improving how well they can localize the seizure focus before possible surgery.
This study looks at how epilepsy affects a brain chemical that helps control breathing and alertness. It uses a special scan to see this chemical, which may help find better treatments for seizures.
This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.
This trial tests a mobile app called EPIDAY that gives you a daily forecast of your seizure risk. It is designed for people with focal epilepsy who have seizures at least two days a month.
This trial tests a new device to help diagnose epilepsy in people whose previous EEG brain monitoring did not give clear answers. If you have drug-resistant epilepsy with at least one seizure a month on average, this study may help find better treatment options.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.